Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,900 Ocular
clinical trials

Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Group of Washington
mi
from
Fairfax, VA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Retinal Consultants PC
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Retina Consultants
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants, San Diego
mi
from
Poway, CA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Black Hills Regional Eye Institute
mi
from
Rapid City, SD
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Care Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Atlantic Retina
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Group of Washington
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke University, Duke Eye Center
mi
from
Durham, NC
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Eye and Ear Infirmary of Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Vitreous-Retina-Macula Consultants of NY,PC
mi
from
New York, NY
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Sierra Eye Associates
mi
from
Reno, NV
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
American Institute of Research
mi
from
Whittier, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Group of Washington
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Health Center
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois Retina Associates
mi
from
Joliet, IL
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Sierra Eye Associates
mi
from
Reno, NV
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ophthalmic Consultants of Long Island
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Eye Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Mundorf Eye Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Abrams Eye Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Global Research Management
mi
from
Glendale, CA
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Shettle Eye Research
mi
from
Largo, FL
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Eye Research Foundation
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Apioc Contact Lens Feasibility
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Eye Associates of Fort Myers
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
North Valley Eye Medical Group, Inc.
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Glaucoma Specialists
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Eye Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Ophthalmic Institute
mi
from
Gainesville, FL
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Silverstein Eye Centers
mi
from
Kansas City, MO
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Eye Research Foundation
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension
Status: Enrolling, Phase III
Updated: 12/31/1969
SPARC Site 11
mi
from
Miami, FL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice
Status: Enrolling
Updated: 12/31/1969
Empire Eye & Laser Center
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt Eye Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Metropolitan Eye Research and Surgery Institute
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Retina and Vitreous Consultants
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
West Coast Retina
mi
from
San Francisco, CA
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Centers, P.C.
mi
from
Tucson, AZ
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Retina Associates
mi
from
Arlington, TX
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Research Center
mi
from
Austin, TX
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Partners
mi
from
Encino, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Northwest, PC
mi
from
Portland, OR
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Associates of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Orange County Retina Medical Group
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
Status: Enrolling, Phase IV
Updated: 12/31/1969
Stein Eye Institute (UCLA)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Abilene, TX
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Fairfield, OH
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Mountain View, CA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Oakland, CA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cataract Clinical Trial
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
Status: Enrolling
Updated: 12/31/1969
Advanced Vision Care
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops
Status: Enrolling
Updated: 12/31/1969
The Ohio State University College of Optometry
mi
from
Columbus, OH
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
Status: Enrolling, Phase IV
Updated: 12/31/1969
Southern College of Optometry
mi
from
Memphis, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
Rutgers-RWJMS
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
Status: Enrolling
Updated: 12/31/1969
Oakland Ophthalmic Surgery
mi
from
Birmingham, MI
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
Status: Enrolling
Updated: 12/31/1969
Florida Eye Microsurgical Institute
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
Status: Enrolling
Updated: 12/31/1969
The Eye Associates of Manatee
mi
from
Bradenton, FL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
Status: Enrolling
Updated: 12/31/1969
Scripps Clinic Medical Group, Inc
mi
from
La Jolla, CA
Click here to add this to my saved trials
Amblyopia Clinical Trial
Augmenting Patching Treatment for Amblyopia With Physical Exercise
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Diagnostic Center
mi
from
Campbell, CA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Partners
mi
from
Encino, CA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Retinal Consultants PC
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina and Vitreous of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Specialty Institute
mi
from
Pensacola, FL
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants, San Diego
mi
from
Poway, CA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Retina
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants
mi
from
SLingerlands, NY
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Care Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
1 … 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 … 29